药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Epoprostenol
Sitaxentan
Sitaxentan may increase the hypotensive activities of Temocapril.
Epoprostenol
Tienilic acid
Tienilic acid may increase the hypotensive activities of Temocapril.
Epoprostenol
Dexpropranolol
Dexpropranolol may increase the hypotensive activities of Temocapril.
Epoprostenol
Sacubitril
The risk or severity of angioedema can be increased when Temocapril is combined with Sacubitril.
Epoprostenol
Nicorandil
Nicorandil may increase the vasodilatory activities of Temocapril.
Epoprostenol
Molsidomine
Molsidomine may increase the hypotensive activities of Temocapril.
Epoprostenol
Sodium aurothiomalate
The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Temocapril is combined with Sodium aurothiomalate.
Epoprostenol
Lithium hydroxide
The serum concentration of Lithium hydroxide can be increased when it is combined with Temocapril.
Epoprostenol
Lithium carbonate
The serum concentration of Lithium carbonate can be increased when it is combined with Temocapril.
Epoprostenol
Lithium citrate
The serum concentration of Lithium citrate can be increased when it is combined with Temocapril.
Epoprostenol
Icatibant
Icatibant may decrease the antihypertensive activities of Temocapril.
Epoprostenol
Semuloparin
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Semuloparin.
Epoprostenol
Drospirenone
Temocapril may increase the hyperkalemic activities of Drospirenone.
Epoprostenol
Dapoxetine
Dapoxetine may increase the orthostatic hypotensive activities of Temocapril.
Epoprostenol
Empagliflozin
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Temocapril.
Epoprostenol
Canagliflozin
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Temocapril is combined with Canagliflozin.
Epoprostenol
Ertugliflozin
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Temocapril.
Epoprostenol
Aprotinin
Aprotinin may decrease the antihypertensive activities of Temocapril.
Epoprostenol
Aliskiren
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Temocapril.
Epoprostenol
Naxitamab
Naxitamab may decrease the antihypertensive activities of Temocapril.